ArticleBMC public health2026
Designing and implementing a prediabetes screening in community pharmacies and online prevention program: findings from the PREDICT study.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundDiabetes is a major public health challenge, driving increased morbidity and healthcare costs. Early detection of prediabetes is essential to halt or reverse its progression to diabetes and its associated complications. Community pharmacy services offer untapped potential for health promotion and early chronic disease detection among asymptomatic adults. Guided by the first three phases of the EPIS framework (Exploration, Preparation, and Implementation), this paper describes the design and implementation of a culturally appropriate community pharmacy-based prediabetes screening and online diabetes prevention service.
methodsThis prospective multicentre mixed-method implementation study, conducted between, employed a three-phase approach to optimize pharmacy service delivery and integration. The Exploration phase involved stakeholder analysis of community members, pharmacists, and physicians, using a survey and semi-structured interviews, to inform service design and implementation strategies. In the Preparation phase, a culturally appropriate pharmacy-based prediabetes screening and prevention service was developed. This process involved conducting focus groups, translating and culturally adapting the Diabetes Prevention Program, developing supporting resources, site selection, and training participating pharmacists. The Implementation phase engaged 15 community pharmacies in the United Arab Emirates. Trained pharmacists delivered evidence-based screening protocols to assess glycemic status using point-of-care HbA1c testing, lifestyle factors, and health behaviors. Participants with identified prediabetes were systematically referred to the online prevention program.
resultsA total of 1611 individuals participated in this study. In the Exploration phase, a survey of community members (n=279) revealed high acceptance of pharmacy-based screening (84%) with 59% considering pharmacies suitable locations. During the Implementation phase, pharmacists successfully screened 1320 participants (62.2% male; mean age 41.0±9.7 years). Of those screened, 24.3% (n=321) were identified with previously undetected prediabetes and 12.0% (n=159) had HbA1c levels consistent with diabetes. The pharmacy-based screening functioned as an entry point for the online prevention program where diabetes educators successfully delivered culturally appropriate personalized sessions promoting adoption of healthier lifestyle behaviors. The participants screening stage lasted between two to four months per pharmacy, and the average duration of the prevention program was six months.
conclusionsFrom a public health perspective, pharmacy-based screening offers a valuable opportunity to increase access to early prediabetes detection and diabetes prevention interventions. The PREDICT study provides a replicable framework for developing and implementing pharmacy-based cardiometabolic screening services that can be adapted across diverse healthcare contexts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.